Pierre-Emmanuel Falcoz

Learn More
OBJECTIVE The twofold aim of this prospective clinical study was to assess the accuracy of procalcitonin as a marker of postoperative infection after thoracic surgery and to compare it with C-reactive protein. METHODS Procalcitonin and C-reactive protein concentrations, clinical symptoms of infection and systemic inflammation were recorded preoperatively(More)
BACKGROUND Identifying patients who will experience lung cancer recurrence after surgery remains a challenge. We aimed to evaluate whether mutant forms of epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) (mEGFR and mKRAS) are useful biomarkers in resected non-small cell lung cancer (NSCLC). METHODS We(More)
Sir, It is with great interest that we read the letter entitled 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metasta-sectomy of colo-rectal cancer. Variation in survival associated with proto-oncogenes is not evidence for effectiveness of metastasectomy'. In their comment on the prognostic value of proto-oncogenes in lung(More)
AIMS Retrospective, monocentric analysis of localized superior sulcus non-small cell cancer (SS-NSCLC), article management. MATERIALS AND METHODS Between 2000 and 2010, 42 patients have been treated for a SS-NSCLC. Median age was 54.7 years (34.5-86.8). Nineteen tumors (45.2%) were stage IIB, 18 were stage IIIA (42.9%) and 5 were stage IIIB (11.9%).(More)
  • 1